A. WOLF, M.D.; H. GRAF, M.D.; W. F. PINGGERA, M.D.; H. K. STUMMVOLL, M.D.; V. MEISINGER, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Accumulation of aluminum in the blood and tissues of patients maintained on chronic hemodialysis may cause "dialysis dementia," frequently leading to death (1). The aluminum content of the dialysis bath fluid or the aluminum-hydroxide (Al [OH]3) gels taken by dialysis patients are responsible for the hyperalbuminemia and the high aluminum body stores (2, 3). In the past 4 years continuous ambulatory peritoneal dialysis has been established in the treatment of patients with end-stage renal disease. To our knowledge no information exists on aluminum kinetics in patients thus treated.
We have measured serum aluminum and aluminum clearances in
WOLF A, GRAF H, PINGGERA WF, et al. Serum Aluminum and Continuous Ambulatory Peritoneal Dialysis. Ann Intern Med. 1980;92:130–131. doi: 10.7326/0003-4819-92-1-130_2
Download citation file:
Published: Ann Intern Med. 1980;92(1):130-131.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use